Elevation Oncology (ELEV) News Today $0.38 0.00 (-0.29%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$0.38 0.00 (-0.50%) As of 07/8/2025 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELEV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Elevation Oncology, Inc. (NASDAQ:ELEV) Receives Average Recommendation of "Hold" from AnalystsJuly 2, 2025 | americanbankingnews.comHAPPY FATHER'S DAY! and $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Elevation Oncology, Inc. (NASDAQ: ELEV)June 15, 2025 | globenewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of ShareholdersJune 12, 2025 | prnewswire.comELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation ...June 12, 2025 | morningstar.comMHC Wainwright & Co. Downgrades Elevation Oncology (ELEV)June 12, 2025 | msn.comConcentra buys out another struggling Boston biotechJune 11, 2025 | bizjournals.comELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc. - ELEVJune 10, 2025 | businesswire.comElevation Oncology stock soars on Concentra merger agreementJune 10, 2025 | au.investing.comElevation Oncology to Be Acquired by Concentra BiosciencesJune 10, 2025 | marketwatch.comConcentra to acquire Elevation in bid to eliminate another biotech ‘zombie’June 10, 2025 | finance.yahoo.comELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. ...June 9, 2025 | gurufocus.comELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to ShareholdersJune 9, 2025 | businesswire.comElevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value RightJune 9, 2025 | prnewswire.comElevation Oncology Reports Q1 2025 Financial ResultsMay 16, 2025 | tipranks.comElevation Oncology Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 15, 2025 | prnewswire.comElevation Oncology reveals promising ADC data for solid tumorsApril 27, 2025 | uk.investing.comElevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025April 25, 2025 | prnewswire.comElevation Oncology (ELEV) Gets a Hold from Leerink PartnersApril 19, 2025 | markets.businessinsider.comElevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025March 25, 2025 | prnewswire.comStephens & Co. Downgrades Elevation Oncology (ELEV)March 25, 2025 | msn.comElevation Oncology downgraded to Equal Weight from Overweight at StephensMarch 24, 2025 | markets.businessinsider.comCitizens Capital Markets Downgrades Elevation Oncology (ELEV)March 22, 2025 | msn.comLeerink Partners Downgrades Elevation Oncology (ELEV)March 21, 2025 | msn.comElevation Oncology downgraded to Market Perform from Outperform at Citizens JMPMarch 21, 2025 | markets.businessinsider.comElevation Oncology price target lowered to $1 from $6 at H.C. WainwrightMarch 21, 2025 | markets.businessinsider.comElevation Oncology (NASDAQ:ELEV) Stock, Short Interest ReportMarch 21, 2025 | benzinga.comElevation Oncology downgraded as it halts lead asset on disappointing trialsMarch 21, 2025 | investing.comElevation Oncology to discontinue development of EO-3021; Advancing EO-1022March 21, 2025 | markets.businessinsider.comElevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70%March 20, 2025 | benzinga.comElevation Oncology stock tumbles on halted drug developmentMarch 20, 2025 | ca.investing.comElevation Oncology slumps on plans to drop cancer candidateMarch 20, 2025 | msn.comElevation Oncology Shares Halt on Layoffs, Discontinued Drug CandidateMarch 20, 2025 | marketwatch.comElevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic OptionsMarch 20, 2025 | prnewswire.comElevation Oncology’s Future in Jeopardy: Financing Challenges Threaten Product DevelopmentMarch 8, 2025 | tipranks.comElevation Oncology Reports 2024 Financial Results and ProgressMarch 7, 2025 | tipranks.comElevation Oncology reports Q4 EPS (18c), consensus (22c)March 7, 2025 | markets.businessinsider.comElevation Oncology sees current cash and equivalents sufficient into 2026March 7, 2025 | markets.businessinsider.comElevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business AchievementsMarch 6, 2025 | prnewswire.comMOC Cancer Care raises $18 million from Elevation CapitalFebruary 26, 2025 | msn.comElevation Oncology to Participate in Upcoming Investor ConferencesFebruary 25, 2025 | prnewswire.comElevation Oncology announces CSO departureFebruary 2, 2025 | msn.comElevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming MilestonesJanuary 13, 2025 | prnewswire.comWilliam Blair Initiates Coverage of Elevation Oncology (ELEV) with Outperform RecommendationJanuary 4, 2025 | msn.comElevation Oncology initiated with an Outperform at William BlairJanuary 3, 2025 | msn.comSynaffix B.V.: Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionDecember 12, 2024 | finanznachrichten.deElevation Oncology enters licensing agreement with Synaffix B.V.December 12, 2024 | markets.businessinsider.comElevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionDecember 12, 2024 | prnewswire.comElevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid TumorsDecember 12, 2024 | prnewswire.comElevation Oncology presents positive Phase 1 results of EO-3021 combinationDecember 6, 2024 | markets.businessinsider.comElevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024December 5, 2024 | prnewswire.com Get Elevation Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ELEV and its competitors with MarketBeat's FREE daily newsletter. Email Address ELEV Media Mentions By Week ELEV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELEV News Sentiment▼-0.380.57▲Average Medical News Sentiment ELEV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELEV Articles This Week▼11▲ELEV Articles Average Week Get Elevation Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ELEV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ENTX News IVVD News FBRX News CHRS News CLLS News CRBP News CLYM News ZNTL News JSPR News EXOZ News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELEV) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
